Telemedicine Lifestyle Coaching for Obesity
(RE-TOOL Trial)
Trial Summary
What is the purpose of this trial?
This trial compares two methods to help obese patients in rural areas lose weight. One method involves regular one-on-one meetings with a doctor, while the other includes group coaching sessions over Zoom plus regular meetings with both a doctor and a coach. The goal is to see which method is more effective at supporting weight loss over time.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Telemedicine Lifestyle Coaching for Obesity?
Research shows that telemedicine, including phone and text support, can effectively help people stick to lifestyle changes and improve health outcomes in obesity management. Additionally, telemedicine has been successful in increasing access to obesity treatment in rural areas, leading to improved weight status and reduced health disparities.12345
Is telemedicine lifestyle coaching for obesity safe for humans?
The research on telemedicine lifestyle coaching for obesity, including models like the Team-Based Model and TelemedTeam, generally focuses on weight management and does not report any specific safety concerns. These programs are designed to be delivered by trained health professionals and often include remote counseling, which is considered safe for participants.45678
How is the Telemedicine Lifestyle Coaching for Obesity treatment different from other obesity treatments?
This treatment is unique because it uses telemedicine to provide lifestyle coaching, making it accessible to people in rural areas who may have limited access to obesity care. It combines personal coaching with a team-based approach, involving primary care providers and other specialists, to support long-term weight loss and health behavior changes.467910
Research Team
Christie Befort, PhD
Principal Investigator
University of Kansas Medical Center
Eligibility Criteria
This trial is for English-speaking rural residents with obesity (BMI >= 30 kg/m2) who can walk unaided and have seen their primary care provider in the past year. They need internet access or a smartphone, and physician clearance to join. People with recent major health events like heart attacks or strokes, those pregnant or planning pregnancy, breastfeeding, having had bariatric surgery recently, or with end-stage diseases are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either quarterly 1:1 meetings with their primary care provider or a group lifestyle intervention over Zoom paired with quarterly team meetings.
Follow-up
Participants are monitored for changes in weight, diet quality, and quality of life.
Treatment Details
Interventions
- Local Care + Model (Behavioral Intervention)
- Team Care Model (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Dr. Steve Stites
University of Kansas Medical Center
Chief Executive Officer
MD from University of Kansas School of Medicine
Dr. Matthias Salathe
University of Kansas Medical Center
Chief Medical Officer
MD from University of Kansas School of Medicine
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School